Clinical Trials in Pittsburgh

Showing 14561-14580 of 21,047 trials

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

NCT00003176

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins82 participantsStarted Mar 1998

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 1< 1 mile

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Find Trials by Condition in Pittsburgh

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

Minocycline Therapy for Management of Adverse Radiation Effects

A Comparative Analysis Between College Park Sidekick Feet and Conventional Stubby Prosthesis

Injection of Autologous Adipose Tissue for Treatment of Osteoarthritis in the Knee

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets